Revenue
0 USD
2024 Q4 · USD
Annual consolidated revenue for 2024: about USD 0, using the latest reported figures. The previous period, 2023, was about USD 5.442M.
8400000 USD
779000 USD
13540000 shares
19.29% · 2.19 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
0 USD
2024-01-01 – 2024-12-31
-8.54 million USD
2024-04-01 – 2025-03-31
-9 million USD
2024-04-01 – 2025-03-31
0 USD
2023-01-01 – 2023-12-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2025-05-15.
Financial data available through: 2024-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 5.44 million
–
Current period
USD 0
–
0 − 5442000 = -5442000 USD
5442000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source0 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 14.1 million
–
Current period
−USD 17.1 million
–
-17100000 − -14100000 = -3000000 USD
-14100000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-17100000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 16.21 million
–
Current period
−USD 11.57 million
–
-11567000 − -16209000 = 4642000 USD
-16209000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-11567000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | 4312000 | 28846000 Derived | -24534000 | 506000 Derived | -25040000 | -19678000 Derived | Source
|
| 2016 2016-01-01 – 2016-12-31 | 8384000 | 45839000 Derived | -37455000 | -223000 Derived | -37232000 | -42154000 Derived | Source
|
| 2017 2017-01-01 – 2017-12-31 | 5341000 | 65314000 Derived | -59973000 | -541000 Derived | -59432000 | -52513000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 6896000 | 62527000 Derived | -55631000 | 1856000 Derived | -57487000 | -18184000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 9091000 | 20184000 Derived | -11093000 | 724000 Derived | -11817000 | -17853000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 1953000 | 43484000 Derived | -41531000 | 21869000 Derived | -63400000 | -19100000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 5442000 | 21165000 Derived | -15723000 | -1623000 Derived | -14100000 | -16209000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 0 | 13532000 Derived | -13532000 | 3568000 Derived | -17100000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Revenue | 5150000 |
|
| 2015 | Revenue | 4312000 |
|
| 2016 | Revenue | 8384000 |
|
| 2017 | Revenue | 5341000 |
|
| 2020 | Revenue | 6896000 |
|
| 2021 | Revenue | 9091000 |
|
| 2022 | Revenue | 1953000 |
|
| 2023 | Revenue | 5442000 |
|
| 2024 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Year over year | No prior comparable period |
|
| 2015 | Year over year | -16.3% |
|
| 2016 | Year over year | 94.4% |
|
| 2017 | Year over year | -36.3% |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 31.8% |
|
| 2022 | Year over year | -78.5% |
|
| 2023 | Year over year | 178.6% |
|
| 2024 | Year over year | -100% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Operating margin | -304.5% |
|
| 2015 | Operating margin | -569% |
|
| 2016 | Operating margin | -446.7% |
|
| 2017 | Operating margin | -1,122.9% |
|
| 2020 | Operating margin | -806.7% |
|
| 2021 | Operating margin | -122% |
|
| 2022 | Operating margin | -2,126.5% |
|
| 2023 | Operating margin | -288.9% |
|
| 2024 | Operating margin | Not reported |
|
| 2014 | Net margin | -306.3% |
|
| 2015 | Net margin | -580.7% |
|
| 2016 | Net margin | -444.1% |
|
| 2017 | Net margin | -1,112.8% |
|
| 2020 | Net margin | -833.6% |
|
| 2021 | Net margin | -130% |
|
| 2022 | Net margin | -3,246.3% |
|
| 2023 | Net margin | -259.1% |
|
| 2024 | Net margin | Not reported |
|
| 2014 | Free cash flow margin | Not reported |
|
| 2015 | Free cash flow margin | -456.4% |
|
| 2016 | Free cash flow margin | -502.8% |
|
| 2017 | Free cash flow margin | -983.2% |
|
| 2020 | Free cash flow margin | -263.7% |
|
| 2021 | Free cash flow margin | -196.4% |
|
| 2022 | Free cash flow margin | -978% |
|
| 2023 | Free cash flow margin | -297.9% |
|
| 2024 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Operating cash flow | Not reported | No source recorded |
| 2015 | Operating cash flow | -19415000 |
|
| 2016 | Operating cash flow | -41925000 |
|
| 2017 | Operating cash flow | -52395000 |
|
| 2020 | Operating cash flow | -17938000 |
|
| 2021 | Operating cash flow | -17853000 |
|
| 2022 | Operating cash flow | -19029000 |
|
| 2023 | Operating cash flow | -16209000 |
|
| 2024 | Operating cash flow | -11567000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Free cash flow | Unavailable | No source recorded |
| 2015 | Free cash flow | -19678000 |
|
| 2016 | Free cash flow | -42154000 |
|
| 2017 | Free cash flow | -52513000 |
|
| 2020 | Free cash flow | -18184000 |
|
| 2021 | Free cash flow | -17853000 |
|
| 2022 | Free cash flow | -19100000 |
|
| 2023 | Free cash flow | -16209000 |
|
| 2024 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Liabilities / assets | 169.8% |
|
| 2015 | Liabilities / assets | 77.6% |
|
| 2016 | Liabilities / assets | 10.6% |
|
| 2017 | Liabilities / assets | 12.6% |
|
| 2020 | Liabilities / assets | 51.1% |
|
| 2021 | Liabilities / assets | 189.5% |
|
| 2022 | Liabilities / assets | 73.8% |
|
| 2023 | Liabilities / assets | 70.2% |
|
| 2024 | Liabilities / assets | 1,264.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Current assets / current liabilities | 1.75× |
|
| 2015 | Current assets / current liabilities | 1.52× |
|
| 2016 | Current assets / current liabilities | 10.31× |
|
| 2017 | Current assets / current liabilities | 7.7× |
|
| 2020 | Current assets / current liabilities | 2.84× |
|
| 2021 | Current assets / current liabilities | 0.78× |
|
| 2022 | Current assets / current liabilities | 1.18× |
|
| 2023 | Current assets / current liabilities | 0.85× |
|
| 2024 | Current assets / current liabilities | 0.08× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | −USD 25.04 million Exact valueExact value: -25040000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.42 million Exact valueExact value: -19415000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 263,000 Exact valueExact value: 263000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.68 million Calculation and evidence-19415000 − 263000 USD Exact free cash flow: -19678000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2016 2016-01-01 – 2016-12-31 | −USD 37.23 million Exact valueExact value: -37232000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 41.93 million Exact valueExact value: -41925000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 229,000 Exact valueExact value: 229000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 42.15 million Calculation and evidence-41925000 − 229000 USD Exact free cash flow: -42154000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 59.43 million Exact valueExact value: -59432000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 52.4 million Exact valueExact value: -52395000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 118,000 Exact valueExact value: 118000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 52.51 million Calculation and evidence-52395000 − 118000 USD Exact free cash flow: -52513000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 61.83 million Exact valueExact value: -61832000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 58.84 million Exact valueExact value: -58844000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 415,000 Exact valueExact value: 415000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.26 million Calculation and evidence-58844000 − 415000 USD Exact free cash flow: -59259000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 31.21 million Exact valueExact value: -31209000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 27.21 million Exact valueExact value: -27208000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 638,000 Exact valueExact value: 638000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 27.85 million Calculation and evidence-27208000 − 638000 USD Exact free cash flow: -27846000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 57.49 million Exact valueExact value: -57487000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.94 million Exact valueExact value: -17938000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 246,000 Exact valueExact value: 246000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.18 million Calculation and evidence-17938000 − 246000 USD Exact free cash flow: -18184000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 11.82 million Exact valueExact value: -11817000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.85 million Exact valueExact value: -17853000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.85 million Calculation and evidence-17853000 − 0 USD Exact free cash flow: -17853000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 63.4 million Exact valueExact value: -63400000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.03 million Exact valueExact value: -19029000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 71,000 Exact valueExact value: 71000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.1 million Calculation and evidence-19029000 − 71000 USD Exact free cash flow: -19100000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 14.1 million Exact valueExact value: -14100000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.21 million Exact valueExact value: -16209000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.21 million Calculation and evidence-16209000 − 0 USD Exact free cash flow: -16209000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 17.1 million Exact valueExact value: -17100000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.57 million Exact valueExact value: -11567000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
71 filings · 2,788 latest values · 2,788 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001445283, 1445283, KA, KANT, PTI, YMTX, edgar:1445283
Also known as KINETA, INC./DE, PROTEOSTASIS THERAPEUTICS INC, PROTEOSTASIS THERAPEUTICS, INC., Proteostasis Therapeutics, Inc., YUMANITY THERAPEUTICS, INC.